Xuejun Janelle Wu - 29 Sep 2023 Form 3 Insider Report for Estrella Immunopharma, Inc. (ESLA)

Role: Director
Signature: /s/ Emily Semon, as attorney-in-fact
Issuer symbol: ESLA
Transactions as of: 29 Sep 2023
Transactions value $: $0
Form type: 3
Filing time: 10 Oct 2023, 16:16:07 UTC
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney.